P3 Health Partners Statistics
Total Valuation
PIII has a market cap or net worth of $95.53 million. The enterprise value is $392.71 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PIII has 7.24 million shares outstanding. The number of shares has increased by 4.87% in one year.
| Current Share Class | 3.32M |
| Shares Outstanding | 7.24M |
| Shares Change (YoY) | +4.87% |
| Shares Change (QoQ) | +156.54% |
| Owned by Insiders (%) | 3.75% |
| Owned by Institutions (%) | 7.35% |
| Float | 1.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.08 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.33
| Current Ratio | 0.33 |
| Quick Ratio | 0.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.55 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.20% |
| Return on Invested Capital (ROIC) | -56.73% |
| Return on Capital Employed (ROCE) | -150.65% |
| Weighted Average Cost of Capital (WACC) | 13.47% |
| Revenue Per Employee | $4.60M |
| Profits Per Employee | -$394,516 |
| Employee Count | 320 |
| Asset Turnover | 2.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.01% in the last 52 weeks. The beta is 0.47, so PIII's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +69.01% |
| 50-Day Moving Average | 3.90 |
| 200-Day Moving Average | 5.30 |
| Relative Strength Index (RSI) | 76.72 |
| Average Volume (20 Days) | 3,780,800 |
Short Selling Information
The latest short interest is 72,094, so 1.00% of the outstanding shares have been sold short.
| Short Interest | 72,094 |
| Short Previous Month | 74,532 |
| Short % of Shares Out | 1.00% |
| Short % of Float | 5.04% |
| Short Ratio (days to cover) | 3.56 |
Income Statement
In the last 12 months, PIII had revenue of $1.47 billion and -$126.25 million in losses. Loss per share was -$38.54.
| Revenue | 1.47B |
| Gross Profit | -10.98M |
| Operating Income | -223.98M |
| Pretax Income | -285.85M |
| Net Income | -126.25M |
| EBITDA | -139.79M |
| EBIT | -223.98M |
| Loss Per Share | -$38.54 |
Full Income Statement Balance Sheet
The company has $25.50 million in cash and $322.67 million in debt, with a net cash position of -$297.17 million or -$41.06 per share.
| Cash & Cash Equivalents | 25.50M |
| Total Debt | 322.67M |
| Net Cash | -297.17M |
| Net Cash Per Share | -$41.06 |
| Equity (Book Value) | -133.17M |
| Book Value Per Share | -43.99 |
| Working Capital | -353.28M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -85.24M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 84.19M |
| Net Borrowing | 70.04M |
| Free Cash Flow | -85.24M |
| FCF Per Share | -$11.78 |
Full Cash Flow Statement Margins
Gross margin is -0.75%, with operating and profit margins of -15.21% and -8.57%.
| Gross Margin | -0.75% |
| Operating Margin | -15.21% |
| Pretax Margin | -19.42% |
| Profit Margin | -8.57% |
| EBITDA Margin | -9.50% |
| EBIT Margin | -15.21% |
| FCF Margin | n/a |
Dividends & Yields
PIII does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.87% |
| Shareholder Yield | -4.87% |
| Earnings Yield | -132.15% |
| FCF Yield | -89.22% |
Analyst Forecast
The average price target for PIII is $14.00, which is 6.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 6.06% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 14, 2025. It was a reverse split with a ratio of 1:50.
| Last Split Date | Apr 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |